381 related articles for article (PubMed ID: 17120485)
1. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
[TBL] [Abstract][Full Text] [Related]
2. Annual report on surveillance of adverse events following immunisation in Australia, 2006.
Lawrence GL; Aratchige PE; Boyd I; McIntyre PB; Gold MS
Commun Dis Intell Q Rep; 2007 Sep; 31(3):269-82. PubMed ID: 17974219
[TBL] [Abstract][Full Text] [Related]
3. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
Lawrence GL; Boyd I; McIntyre PB; Isaacs D
Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
[TBL] [Abstract][Full Text] [Related]
5. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of adverse events following immunisation: Australia, 2000-2002.
Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
[TBL] [Abstract][Full Text] [Related]
7. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
[TBL] [Abstract][Full Text] [Related]
8. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
[TBL] [Abstract][Full Text] [Related]
9. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of adverse events following immunisation in Australia annual report, 2013.
Mahajan D; Dey A; Cook J; Harvey B; Menzies R; Macartney K
Commun Dis Intell Q Rep; 2015 Sep; 39(3):E369-86. PubMed ID: 26620351
[TBL] [Abstract][Full Text] [Related]
11. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of adverse events following immunisation in Australia annual report, 2014.
Dey A; Wang H; Quinn HE; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E377-E390. PubMed ID: 28278414
[TBL] [Abstract][Full Text] [Related]
13. Active SMS-based influenza vaccine safety surveillance in Australian children.
Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of adverse events following immunisation in Australia annual report, 2016.
Dey A; Wang H; Quinn H; Cook J; Macartney K
Commun Dis Intell (2018); 2018; 42():. PubMed ID: 30626306
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia.
Littlejohn ES; Clothier HJ; Perrett KP; Danchin M
Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of adverse events following immunisation in Australia, 2012.
Mahajan D; Dey A; Cook J; Harvey B; Menzies RI; Macartney KM
Commun Dis Intell Q Rep; 2014 Sep; 38(3):E232-46. PubMed ID: 25391415
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
19. Adverse events following immunization in Ontario's female school-based HPV program.
Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
[TBL] [Abstract][Full Text] [Related]
20. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
